Pfizer Drops Exubera
Since its market release in early 2006, Exubera has faced an uphill battle winning widespread physician and consumer adaption. Now, manufacturer Pfizer has decided to pull the product from its portfolio. From Pfizer's third quarter earnings release yesterday:
"[W]e made an important decision regarding Exubera, a product for which we initially had high expectations,” said Jeff Kindler, Chairman and Chief Executive Officer. “Despite our best efforts, Exubera has failed to gain the acceptance of patients and physicians. We have therefore concluded that further investment in this product is unwarranted.”We will work with physicians to transition Exubera patients to other treatment options in the next three months. We remain committed to investing significant resources in the development of new and innovative medicines to manage diabetes, including monitoring inhalation technologies and other innovative delivery systems for insulin and other medicines.”
RELATED: Inhaled Insulin
Comments
- At 09:15 PM on Sun, Oct 21, 2007 Katie wrote:
I'm not surprised that Exubera has not received much popularity among physicians and people with diabetes. I don't blame people with diabetes, who chose not to switch to inhaled insulin, for feeling a little skeptical about it. Besides they have been using insulin pen or insulin pump for so many years are much more confortable with it and have had great success with controlling blood sugars. So why switch? I personally don't believe that inhaled insulin would work as well at controlling blood sugars. That's why I chose not to switch to Exubera. Plus, healthy lungs could possibly be damaged or deteriorated by inhaled insulin after long term use.
Happy pumper for 5 years.
I have been using Exubera for over 6 months and have very good results...I am disappointed that it is going off the market...is there any way I can continute to get it?